Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2023-05-09 Director's Dealing
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2023-05-09 English
10-Q
Interim / Quarterly Report Q1 2023
2023-05-03 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes details about the company's quarterly results announcement (Item 2.02), but the actual financial results are referenced as a press release attached as Exhibit 99.1, not included in the document itself. The document also contains detailed voting results from the company's 2023 Annual Meeting of Stockholders (Item 5.07), including votes on director elections, auditor ratification, executive compensation, and plan amendments. This detailed disclosure of shareholder voting outcomes corresponds to a Declaration of Voting Results. The document is not an Annual Report, Earnings Release, or Management Discussion and Analysis, as it does not contain comprehensive financial statements or management commentary. It is not a Proxy Solicitation or Presentation. The presence of detailed vote counts and resolutions approved at the Annual Meeting clearly identifies this as a Declaration of Voting Results filing. Therefore, the appropriate classification is DVA (Declaration of Voting Results & Voting Rights Announcements). The document length (6179 characters) and content support this classification with high confidence.
2023-05-03 English
FORM 4/A
Director's Dealing
2023-03-23 English
FORM 4/A
Director's Dealing
2023-03-23 English
ARS
Annual Report
2023-03-17 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.